Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Effects of Remimazolam Combined With Remifentanil on Quality of Recovery After Ambulatory Hysteroscopic Surgery: a Prospective, Observational Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05320016
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:43.234164+00:00
Published At
2022-04-11T00:00:00+00:00
Record Updated At
2022-04-11
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Day Surgery", "Patient Outcome Assessment", "Quality of Recovery", "Remimazolam"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-04-11"
protocolSection.identificationModule.nctId
"NCT05320016"
protocolSection.identificationModule.officialTitle
"Effects of Remimazolam Combined With Remifentanil on Quality of Recovery After Ambulatory Hysteroscopic Surgery: a Prospective, Observational Study"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Day Surgery (protocolSection.conditionsModule.conditions)
  • Patient Outcome Assessment (protocolSection.conditionsModule.conditions)
  • Quality of Recovery (protocolSection.conditionsModule.conditions)
  • Remimazolam (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.